That's more of a question for companies like e.g. Biontech. But in general, it can be said that cancer research has been looking at mRNA technology for the past 20 years, and in the field of cancer immunotherapy, progress has also been increasing in recent years. For example, an abstract on the subject was recently published in the cancer network: www.cancernetwork.com/view/messenger-rna-vaccines-beckoning-of-a-new-era-in-cancer-immunotherapy.
@@__________6597 You're welcome. If you are interested in more details: Evonik just started a cooperation with Stanford University, working on a technology to deliver mRNA to tissues and organs that goes beyond the capabilities of lipid nanoparticles: corporate.evonik.de/en/media/press-releases/corporate/evonik-and-stanford-university-sign-research-collaboration-evonik-to-market-and-develop-new-drug-del-159498.html
That's more of a question for companies like e.g. Biontech. But in general, it can be said that cancer research has been looking at mRNA technology for the past 20 years, and in the field of cancer immunotherapy, progress has also been increasing in recent years. For example, an abstract on the subject was recently published in the cancer network: www.cancernetwork.com/view/messenger-rna-vaccines-beckoning-of-a-new-era-in-cancer-immunotherapy.
Thus, civilization and science save humanity. Thank you!
Guten morgen, when is possible build nanotecnology medicine for kill cancer or infections? Tx
That's more of a question for companies like e.g. Biontech. But in general, it can be said that cancer research has been looking at mRNA technology for the past 20 years, and in the field of cancer immunotherapy, progress has also been increasing in recent years. For example, an abstract on the subject was recently published in the cancer network: www.cancernetwork.com/view/messenger-rna-vaccines-beckoning-of-a-new-era-in-cancer-immunotherapy.
@@EvonikIndustries tx
@@__________6597 You're welcome. If you are interested in more details: Evonik just started a cooperation with Stanford University, working on a technology to deliver mRNA to tissues and organs that goes beyond the capabilities of lipid nanoparticles: corporate.evonik.de/en/media/press-releases/corporate/evonik-and-stanford-university-sign-research-collaboration-evonik-to-market-and-develop-new-drug-del-159498.html
Finally goverment not blocked.....
good
Thanks to the employees of this company because they are looking at the most important medical field that serves humanity
That's more of a question for companies like e.g. Biontech. But in general, it can be said that cancer research has been looking at mRNA technology for the past 20 years, and in the field of cancer immunotherapy, progress has also been increasing in recent years. For example, an abstract on the subject was recently published in the cancer network: www.cancernetwork.com/view/messenger-rna-vaccines-beckoning-of-a-new-era-in-cancer-immunotherapy.